mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.007 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.68 |
0.01 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.02 |